CRBP logo

CRBP

Profile

Full Name

Corbus Pharmaceuticals Holdings, Inc.

Ticker Symbol

CRBP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 27, 2014

Indexes

Not included

Website

http://www.corbuspharma.com

Employees

28

Key Details

Price

$6.03(+1.86%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.68(+64.31% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$6.03
CRBP price is $6.03

30-Day Relative Volume

0.60
CRBP 30-day relative volume is 0.60

Price Performance

Price Most recent change

+1.86%
CRBP price was up +1.86% on Apr 17, 2025

Price YTD change

-48.9%
CRBP price is down -48.9% since January 1st

Price 1-year change

-83.77%
CRBP price is down -83.77% year-on-year

Price 3-year change

-46.4%
CRBP price is down -46.4% over the past 3 years

Price Range

Price All-time high

$323.40
CRBP price is currently -98.14% below its historical high of $323.40

Price 3-year low

$2.11
CRBP price is currently +185.78% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$73.76M
CRBP market capitalization is $73.76 million

Market cap 3-year change

+57.03%
CRBP market capitalization is up +57.03% over the past 3 years

Market cap All-time high

$766.45M
CRBP market capitalization is currently -90.38% below its historical high of $766.45 million

Market cap sector rank

43.95%
CRBP market capitalization is higher than 43.95% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+16.42%
CRBP shares outstanding is up +16.42% year-on-year

Shares Outstanding 3-Year Change

+192.97%
CRBP shares outstanding is up +192.97% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.12
CRBP beta is 1.12

200-day SMA

$24.50
CRBP price is currently -75.39% below its 200-day simple moving average

50-day SMA

$6.85
CRBP price is currently -12.00% below its 50-day simple moving average

RSI

49.05
CRBP 14-day relative strength index is 49.05

Volume

0.60
CRBP 30-day relative volume is 0.60

ATR

$0.45
CRBP average true range is $0.45

10-day Historical Volatility

48.11%
CRBP 10-day historical volatility is 48.11%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
CRBP annual revenue value is unknown

Revenue Analysts estimate

$1.11M
CRBP annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
CRBP annual revenue 1-year change is unknown

Revenue Sector rank

-
CRBP annual revenue is unknown

EPS

EPS

-$3.68
CRBP annual earnings per share is -$3.68

EPS Analysts estimate

-$4.15
CRBP annual earnings per share is currently -11.35% lower than the consensus analysts' forecast

EPS 1-year change

+64.31%
CRBP annual earnings per share is up +64.31% year-on-year

EPS Sector rank

24.52%
CRBP annual earnings per share is higher than 24.52% of companies in Healthcare sector

Profit

Gross profit

-
CRBP annual gross profit value is unknown

Gross margin

-
CRBP annual gross profit margin value is unknown

Operating profit

-$48.72M
CRBP annual operating income is -$48.72 million

Operating margin

-
CRBP annual operating profit margin value is unknown

Net income

-$40.21M
CRBP annual net profit is -$40.21 million

Net margin

-
CRBP annual net profit margin value is unknown

Expenses

Total expenses

$48.72M
CRBP annual total expenses is $48.72 million

Operating expenses

$48.72M
CRBP annual total operating expenses is $48.72 million

Cost of goods sold

-
CRBP annual cost of goods sold value is unknown

Selling, general & administrative expenses

$16.50M
CRBP annual SGA is $16.50 million

Depreciation and amortization

$588.00K
CRBP annual depreciation & amortization is $588.00 thousand

Interest expense

$1.87M
CRBP annual interest expense is $1.87 million

Income tax

-
CRBP annual income tax value is unknown

EBIT & EBITDA

EBIT

-$38.34M
CRBP annual earnings before interest & taxes is -$38.34 million

EBITDA

-$38.34M
CRBP annual EBITDA is -$38.34 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$155.88M
CRBP annual total assets is $155.88 million

Non current assets

$2.90M
CRBP annual long term assets is $2.90 million

Current assets

$152.98M
CRBP annual total current assets is $152.98 million

Cash and cash equivalents

$17.20M
CRBP annual cash & cash equivalents is $17.20 million

Accounts receivable

-
CRBP annual accounts receivable value is unknown

Inventory

-
CRBP annual inventory value is unknown

Liabilities

Total liabilities

$13.45M
CRBP annual total liabilities is $13.45 million

Long term liabilities

$1.63M
CRBP annual total long term liabilities is $1.63 million

Current liabilities

$11.82M
CRBP annual total current liabilities is $11.82 million

Accounts payable

$4.79M
CRBP annual accounts payable is $4.79 million

Debt

Total debt

$3.24M
CRBP annual total debt is $3.24 million

Total debt 1-year change

-84.49%
CRBP annual total debt is down -84.49% year-on-year

Long term debt

$1.63M
CRBP annual long term debt is $1.63 million

Short term debt

$1.61M
CRBP annual short term debt is $1.61 million

Equity & Capital

Shareholders equity

$142.43M
CRBP annual stockholders equity is $142.43 million

Book value

$142.43M
CRBP annual book value is $142.43 million

Retained earnings

-$476.89M
CRBP annual retained earnings is -$476.89 million

Working capital

$141.16M
CRBP annual working capital is $141.16 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$41.79M
CRBP annual cash flow from operations is -$41.79 million

Cash from operations 1-year change

-15.77%
CRBP annual cash flow from operations is down -15.77% year-on-year

Cash from investing

-$121.31M
CRBP annual cash flow from investing activities is -$121.31 million

Cash from investing 1-year change

-440.36%
CRBP annual cash flow from investing activities is down -440.36% year-on-year

Cash from financing

$166.58M
CRBP annual cash flow from financing activities is $166.58 million

Cash from financing 1-year change

+6004.93%
CRBP annual cash flow from financing activities is up +6004.93% year-on-year

CAPEX

CAPEX

-
CRBP annual capital expenditures value is unknown

CAPEX 1-year change

-
CRBP annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$41.79M
CRBP annual free cash flow is -$41.79 million

Free cash flow 1-year change

-15.77%
CRBP annual free cash flow is down -15.77% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CRBP annual gross profit margin value is unknown

Operating margin

-
CRBP annual operating profit margin value is unknown

Net margin

-
CRBP annual net profit margin value is unknown

ROA & ROE

ROA

-25.80%
CRBP annual return on assets is -25.80%

ROE

-28.23%
CRBP annual return on equity is -28.23%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CRBP price to earnings ratio value is unknown

PE ratio Sector rank

-
CRBP price to earnings ratio is unknown

PB Ratio

PB ratio

0.52
CRBP price to book ratio is 0.52

PB ratio Sector rank

30.34%
CRBP price to book ratio is higher than 30.34% of companies in Healthcare sector

PS Ratio

PS ratio

-
CRBP price to sales ratio value is unknown

PS ratio Sector rank

-
CRBP price to sales ratio is unknown

Enterprise value

Enterprise value

$59.80M
CRBP enterprise value is $59.80 million

Enterprise value Sector rank

43.72%
CRBP enterprise value is higher than 43.72% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.45
CRBP EV/EBITDA is -1.45

EV/EBITDA Sector rank

37.6%
CRBP EV/EBITDA is higher than 37.6% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

12.94
CRBP annual current ratio is 12.94

Quick ratio

-
CRBP annual quick ratio value is unknown

Leverage

Debt to equity

0.02
CRBP annual debt to equity ratio is 0.02

Interest coverage ratio

-20.48
CRBP annual interest coverage ratio is -20.48

Risk & Stability

Piotroski F-Score

-
CRBP piotroski f-score value is unknown

Altman Z-Score

-
CRBP altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 12, 25 HC Wainwright & Co.
Buy
Mar 11, 25 Jefferies
Buy
Feb 28, 25 William Blair
Outperform
Feb 18, 25 HC Wainwright & Co.
Buy
Feb 10, 25 HC Wainwright & Co.
Buy
Dec 2, 24 Piper Sandler
Overweight
Aug 7, 24 RBC Capital
Outperform
Aug 7, 24 Oppenheimer
Outperform
Aug 6, 24 HC Wainwright & Co.
Buy
Jul 10, 24 Oppenheimer
Outperform

Institutional Ownership

Similar stocks

Telomir Pharmaceuticals (TELO)
Whitehawk Therapeutics (WHWK)
TNYA logo
Tenaya Therapeutics (TNYA)
CARA logo
Cara Therapeutics (CARA)
IGMS logo
IGM Biosciences (IGMS)
ASMB logo
Assembly Biosciences (ASMB)
ADAG logo
Adagene (ADAG)
CNTX logo
Context Therapeutics (CNTX)
UNCY logo
Unicycive Therapeutics (UNCY)
  • What is the ticker symbol for Corbus Pharmaceuticals Holdings?
  • Does Corbus Pharmaceuticals Holdings pay dividends?
  • What sector is Corbus Pharmaceuticals Holdings in?
  • What industry is Corbus Pharmaceuticals Holdings in?
  • What country is Corbus Pharmaceuticals Holdings based in?
  • When did Corbus Pharmaceuticals Holdings go public?
  • Is Corbus Pharmaceuticals Holdings in the S&P 500?
  • Is Corbus Pharmaceuticals Holdings in the NASDAQ 100?
  • Is Corbus Pharmaceuticals Holdings in the Dow Jones?
  • When was Corbus Pharmaceuticals Holdings's last earnings report?
  • When does Corbus Pharmaceuticals Holdings report earnings?
  • Should I buy Corbus Pharmaceuticals Holdings stock now?

What is the ticker symbol for Corbus Pharmaceuticals Holdings?

The ticker symbol for Corbus Pharmaceuticals Holdings is NASDAQ:CRBP

Does Corbus Pharmaceuticals Holdings pay dividends?

No, Corbus Pharmaceuticals Holdings does not pay dividends

What sector is Corbus Pharmaceuticals Holdings in?

Corbus Pharmaceuticals Holdings is in the Healthcare sector

What industry is Corbus Pharmaceuticals Holdings in?

Corbus Pharmaceuticals Holdings is in the Biotechnology industry

What country is Corbus Pharmaceuticals Holdings based in?

Corbus Pharmaceuticals Holdings is headquartered in United States

When did Corbus Pharmaceuticals Holdings go public?

Corbus Pharmaceuticals Holdings's initial public offering (IPO) was on October 27, 2014

Is Corbus Pharmaceuticals Holdings in the S&P 500?

No, Corbus Pharmaceuticals Holdings is not included in the S&P 500 index

Is Corbus Pharmaceuticals Holdings in the NASDAQ 100?

No, Corbus Pharmaceuticals Holdings is not included in the NASDAQ 100 index

Is Corbus Pharmaceuticals Holdings in the Dow Jones?

No, Corbus Pharmaceuticals Holdings is not included in the Dow Jones index

When was Corbus Pharmaceuticals Holdings's last earnings report?

Corbus Pharmaceuticals Holdings's most recent earnings report was on Mar 11, 2025

When does Corbus Pharmaceuticals Holdings report earnings?

The next expected earnings date for Corbus Pharmaceuticals Holdings is May 7, 2025

Should I buy Corbus Pharmaceuticals Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page